Natco Pharma to raise Adcock Ingram stake to 49% for ₹1,069 crore

board approved acquiring 19.6 million shares in Adcock Ingram for ₹1,069 crore to raise its stake to 49% and investing ₹1,400 crore in its South African subsidiary, targeting completion by July 2026. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.